Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Clinical trial NCT07374796 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07374796
Sponsor: University of Maryland, Baltimore
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer (Locally Advanced or Metastatic)Healthy Volunteers (HV)Unhealthy Volunteers Breast Cancer Screening

Start date: 2026-06-01
Primary completion: 2032-06-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.